GO
Loading...

Europe Video

Lars Rebien Sørensen, CEO of Novo Nordisk, says its diabetes drug Tresiba could come to the U.S. market at the start of 2016.

Worried about UK politics: Pro     Thu, 7 Aug '14 | 3:00 AM ET

Jessica Ground, global head of stewardship at Schroders, says she is worried about the effect of the outcome of the Scottish referendum, the U.K.'s membership of the EU and the next general election on markets.

Beat Wittmann, CEO of TCMG Asset Management, says investors should by the DAX on its lows as it is going to rise 50 percent over the next year.

European stocks opened flat-to-lower on Thursday, with worsening tensions between the West and Russia still in focus and a raft of earning reports due.

Simon Wells,chief U.K. economist at HSBC, says that until there is a rise in real terms income, the Bank of England will be "cautious" about raising interest rates.

Professor Peter Bofinger, member of the German Council of Economic Experts, says quantitative easing by the ECB could push Bund yields lower and cause "uproar" in Germany.

Igor Vayn, CEO of Renaissance Capital, says Russian businesses are "adapting" to a tough economic environment and looking for growth.

Martin Senn, CEO of Zurich Insurance, says the slight profit miss in the second quarter was due to the "one off" effect of higher taxes.

Julian Roberts, CEO of Old Mutual, says the biggest issue for the company is the end of quantitative easing by the Federal Reserve.

Samir Brikho, CEO of AMEC, says talk of energy independence in Europe and the U.S. is "ramping up" in the wake of tensions with Russia.

Italy must not give up on reform: Pro     Thu, 7 Aug '14 | 1:45 AM ET

Marco Gubitosi, partner at Legance Avvocati Associati, says Italy's economy looks good in the long term but the government must continue with reform.

Vitas Vasiliauskas, governor of the Bank of Lithuania, says the euro zone is not sick but countries need to carry out structural reform to "survive".

Igor Vayn, CEO of Renaissance Capital, says Russia is an "important" part of the global financial system and won't disappear from investors' radar despite sanctions on the country.

Should markets fear 'Putin effect'?     Wed, 6 Aug '14 | 11:30 AM ET

Cristian Maggio, emerging market strategist at TD Securities, and Holger Schmieding, chief economist at Berenberg Bank, discuss whether both the euro zone and emerging markets could be hit by a "Putin effect".

Why Ebola epidemic is out of control     Wed, 6 Aug '14 | 11:30 AM ET

Jimmy Whitworth, head of population health at the Wellcome Trust, discusses why the latest Ebola outbreak is so serious. He says more tests of experimental drugs and vaccines need to be done.

StanChart: Some headwinds to dissipate     Wed, 6 Aug '14 | 11:15 AM ET

Ian Gordon, equity research analyst at S&P Capital IQ, discusses Standard Chartered's results, and says the group's losses should be lower in the second half.

Lundin Petroleum 'past the worst': CEO     Wed, 6 Aug '14 | 11:15 AM ET

Ashley Heppenstall, CEO of Lundin Petroleum, says delays in its Norway project have negatively impacted production, but that the group should now be "past the worst".

Moody's Investors Service has put a negative outlook on the U.K. banking sector. Johannes Wassenberg, managing director at Moody's, explains that the changing regulatory framework will add pressure on U.K. lenders.

European market closes lower     Wed, 6 Aug '14 | 11:30 AM ET

European shares closed lower on Wednesday with investors reacting to disappointing data and concerns that tensions between Russia and Ukraine could escalate further.

Mondelez has 'strong portfolio': Pro     Wed, 6 Aug '14 | 5:50 AM ET

Erin Lash, analyst at Morningstar, discusses Mondelez ahead of the group's results and outlines why she is "optimistic" for the company on the long term.

Ed Mullane, TMT sector editor at the Mergermarket Group, discusses 21rst Century Fox's strategy regarding Time Warner and says that it is likely to "let things die down" for a little while.

Dr. Andrew Easton, professor at Warwick University, discusses the latest developments in the Ebola outbreak and the use of an experimental drug on two infected U.S. citizens.

What next for T-Mobile US?     Wed, 6 Aug '14 | 5:35 AM ET

Tuna Amobi, senior media and entertainment equity analyst at S&P Capital IQ, says Iliad could improve its bid for T-Mobile U.S. and that other players could enter the race - such as Dish Network.

Italy back in recession     Wed, 6 Aug '14 | 5:00 AM ET

Piers Curran, head of trading at Amplify Trading, says Italy and France are the euro zone's biggest concerns and that markets shouldn't expect the ECB to act until October.

Kobsidthi Silpachai, head of capital markets research at Kasikorn Research, says the Thai government is committed to keeping inflation down and that the country's growth should be below trend this year.

BoE to raise rates in November?     Wed, 6 Aug '14 | 4:30 AM ET

Michael Sneyd, foreign exchange strategist at BNP Paribas, comments on the U.K. economy following the release of the latest manufacturing data.

Luis Costa, head of CEEMEA FX and rates strategy at Citi, discusses the prospects of the euro and why analysts have been wrong on its price movement.

Walgreens to acquire Boots     Wed, 6 Aug '14 | 4:06 AM ET

U.S. giant Walgreens is expected to buy the remaining stake in the U.K.'s Alliance Boots, but the deal is unlikely to include plans for tax inversion, CNBC's Catherine Boyle reports.

David Cole, CFO of Swiss Re, says the company is "on track" to deliver its full year targets.

Alex DeGroote, media analyst at Peel Hunt, says Time Warner will have to prove that it has an organic growth strategy to shareholders after the takeover from 21st Century Fox collapsed.

Contact Europe Video

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More